| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9839 |
| Human Intestinal Absorption | HIA+ | 0.9947 |
| Caco-2 Permeability | Caco2+ | 0.8562 |
| P-glycoprotein Substrate | Substrate | 0.7313 |
| P-glycoprotein Inhibitor | Inhibitor | 0.8214 |
| Inhibitor | 0.7761 |
| Renal Organic Cation Transporter | Inhibitor | 0.8484 |
| Distribution |
| Subcellular localization | Mitochondria | 0.5455 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7349 |
| CYP450 2D6 Substrate | Substrate | 0.9107 |
| CYP450 3A4 Substrate | Substrate | 0.7259 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.5603 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9160 |
| CYP450 2D6 Inhibitor | Inhibitor | 0.8695 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9001 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.7341 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7599 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9127 |
| Inhibitor | 0.7473 |
| AMES Toxicity | Non AMES toxic | 0.8210 |
| Carcinogens | Non-carcinogens | 0.8817 |
| Fish Toxicity | High FHMT | 0.9733 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9508 |
| Honey Bee Toxicity | Low HBT | 0.8372 |
| Biodegradation | Not ready biodegradable | 0.9936 |
| Acute Oral Toxicity | III | 0.5740 |
| Carcinogenicity (Three-class) | Non-required | 0.7129 |